Prostate Cancer Treatment Options
There are several treatment options available for prostate cancer, each with its own benefits and risks. These are some of the factors that go into deciding your prostate cancer treatment
- Cancer stage & grade: How advanced and aggressive the cancer is (e.g., Gleason score, PSA level).
- Tumour location & spread: Whether it's confined to the prostate or has metastasised.
- Patient preferences: Desire to avoid certain side effects (e.g., incontinence, erectile dysfunction).
Prostate Cancer Treatment Options
A successful non-invasive treatment that uses ultrasound waves to target and destroy cancerous tissue with precision
Learn More
A successful minimally-invasive treatment that delivers electrical energy to target and destroy cancerous prostate tissue with precision
Learn More
Focal therapy focuses on treating only the specific areas of the prostate affected by cancer
Learn More
The most common treatment options recommended when you are first diagnosed with prostate cancer
Learn More
Learn More About Prostate Cancer Treatment Options
Get Expert Advice & The Latest Research
Subscribe to our newsletter to receive the latest updates, expert insights, and breakthrough research on prostate cancer-delivered straight to your inbox.
Choosing Between Prostate Cancer Treatment Options
| Treatment Type | Invasiveness | Side effects & Risks | Recovery Time | Ideal Candidate |
|---|---|---|---|---|
| Active Surveillance | Low | Minimal | Ongoing | Low-risk cases |
| Surgery | High | High | 6-8 weeks | Localised Cancer |
| Radiation Therapy | Moderate | Moderate | 4-6 weeks | Various Stages |
| Chemotherapy | High | High | Ongoing | Advanced Stages |
| Focal Therapy | Low | Low | 1-2 weeks | Localised, intermediate-risk cancer |
Learn More
Hear from some of our patients about the effect focal therapy has had on their lives.
Questions to ask your doctor or nurse
Ask about all available options for your specific diagnosis — including active surveillance, focal therapy (HIFU and NanoKnife), surgery, and radiotherapy. Your consultant should explain which options suit your cancer stage, Gleason score, and PSA level.
For detailed information about specific focal therapy options, see our HIFU treatment page and NanoKnife treatment page.
Key questions include: How likely is incontinence or erectile dysfunction? How long is recovery? Will I need time off work? Can I return to normal activities?
Side effect profiles vary significantly between treatments. Focal therapy generally has the lowest side-effect rates, while surgery and radiotherapy carry higher risks to continence and sexual function.
Key things to ask include how many procedures the clinic performs, the consultant's experience and GMC registration, whether MRI-fusion guidance is used, and whether the clinic publishes outcome data.
The Focal Therapy Clinic has completed more than 2,000+ focal therapy procedures, delivered by GMC-registered consultant urologists across seven UK centres.
Ask about retreatment options and what your choices would be if cancer recurs. Focal therapy preserves the prostate, meaning repeat treatment or switching to surgery or radiotherapy remains possible. After surgery, the prostate is removed and retreatment options are more limited.
A typical schedule includes a PSA test and recovery check at six weeks, a PSA test and review at three months, another PSA test and possible MRI at six months, and a full MRI and possible biopsy at twelve months, followed by annual PSA monitoring.
You should contact the clinic urgently if you develop difficulty passing urine, symptoms of infection or ongoing pain.
Frequently asked questions
Active Surveillance: Regular monitoring through PSA tests and MRI scans, suitable for low-risk, slow-growing cancers that may not require immediate treatment.
Focal Therapy: NICE-approved, minimally invasive treatments targeting only the cancerous tissue:
- HIFU: Uses focused ultrasound heat. Best for posterior tumours.
- NanoKnife IRE: Uses electrical pulses. Best for anterior tumours.
Radical Prostatectomy: Complete surgical removal of the prostate. Major surgery requiring 1–3 days hospital stay with 4–6 weeks recovery.
Radiotherapy: External beam radiation or brachytherapy delivered over multiple sessions. Non-surgical whole-gland approach.
Your consultant urologist will recommend options based on your cancer characteristics and personal circumstances.
Key differences:
| Outcome | Focal Therapy | Surgery | Radiation |
|---|---|---|---|
| Urinary continence | 93–100% preserved | 60–85% preserved | 90–95% preserved |
| Sexual function | 75–98% preserved | 13–67% preserved | 50–80% preserved |
| Recovery time | Days to 1–2 weeks | 4–6 weeks | Varies |
| Hospital stay | Outpatient to 1 day | 1–3 days | Outpatient |
Research shows focal therapy achieves comparable 5-year cancer-specific survival (99–100%) to radical treatments while maintaining better quality of life.
Focal therapy is repeatable and keeps all future treatment options available.
- Gleason score 6 (Grade Group 1)
- PSA under 10 ng/ml
- Small tumour volume
- Early stage disease (T1–T2a)
The protocol includes PSA tests every 3–6 months, regular MRI scans, and biopsies as needed. Treatment starts if the cancer shows progression.
Many men remain safely on surveillance for years, though 30–40% may eventually need treatment. For intermediate-risk patients, focal therapy offers an alternative.
Cancer characteristics:
- Stage and Gleason score
- PSA level
- Tumour location (posterior suits HIFU; anterior suits NanoKnife)
- Number and size of lesions
Personal factors:
- Age and overall health
- Life expectancy (10+ years ideally)
- Current urinary and sexual function
- Other medical conditions
Your priorities:
- Preserving sexual function and continence
- Minimising recovery time
- Keeping future options open
- Cost and insurance considerations
Your consultant will assess MRI and biopsy results to recommend the most suitable approach.
After focal therapy:
- Can be safely repeated (15–20% need retreatment within 5 years)
- All options remain open: repeat focal therapy, surgery, or radiotherapy
- Retreatment maintains good functional outcomes
After surgery:
- The prostate is removed
- Radiotherapy may treat recurrence
- No repeat procedure possible
After radiotherapy:
- Salvage options limited due to tissue changes
- Surgery carries higher risks after radiation
Focal therapy allows a “treat and preserve” approach, keeping your future options open.
- Procedure volume
- Consultant experience and GMC registration
- MRI-fusion guidance technology
- Published outcomes
- Multi-disciplinary team access
The Focal Therapy Clinic team has performed over 2,000 focal therapy procedures across the UK, led by experienced GMC-registered urologists.
- 5-year cancer-specific survival: 99–100%
- 5-year metastasis-free survival: 98–100%
- 12-month significant cancer-free rate: 79–86%
Functional outcomes:
- Continence preserved: 93–100%
- Sexual function preserved: 75–98%
Common temporary effects:
- Urinary frequency or urgency
- Mild discomfort
- Blood in urine
Less common:
- Urethral stricture (2–3%)
- Erectile changes (15–20%)
- UTI (<5%)
| Timepoint | Assessment |
|---|---|
| 6 weeks | PSA test, recovery review |
| 3 months | PSA test, clinical assessment |
| 6 months | PSA test, possible MRI |
| 12 months | PSA, MRI, possible biopsy |
| Ongoing | Annual PSA; MRI as needed |
Monitoring checks PSA trends, MRI changes, and new symptoms.

Learn more about Focal Therapy and Prostate Cancer
Can Exercise Before Prostate Cancer Treatment Improve Your Recovery?
“Nobody Should Die of This”: Why Elvin Box Is Campaigning for Earlier Prostate Cancer Testing
How Can You Make Sure Focal Therapy Is Discussed at Your MDT Meeting?
Any questions?
If you've got any questions about your prostate cancer diagnosis or want to know more about your treatment options, don't hesitate to get in touch with our friendly, knowledgeable team.
Contact the team
Reference List
Ahmed HU et al. (2015). Focal therapy for localised prostate cancer: a systematic review of the literature. Nature Reviews Urology.
Ganzer R, Fritsche HM, Brandtner A, et al. (2017). Five-year outcome of HIFU treatment for localised prostate cancer. Urologia Internationalis.
The Focal Therapy Clinic - Prostate Cancer Treatments (Internal Resource).
NHS Resources on Prostate Cancer (Internal/External Resource).
Subscribe to our newsletter
Get expert advice & the latest prostate cancer research - straight to your inbox.





